Full Text View
Tabular View
No Study Results Posted
Related Studies
Peptide Vaccination in Treating Patients With Esophageal Cancer
This study is currently recruiting participants.
Study NCT00682227   Information provided by University of Yamanashi
First Received: May 20, 2008   Last Updated: May 23, 2008   History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study
About Study Results Reporting on ClinicalTrials.gov
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2009
  Estimated Primary Completion Date: December 2008 (Final data collection date for primary outcome measure)
No publications provided by University of Yamanashi

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Kono K, Mizukami Y, Daigo Y, Takano A, Masuda K, Yoshida K, Tsunoda T, Kawaguchi Y, Nakamura Y, Fujii H. Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer. Cancer Sci. 2009 Aug;100(8):1502-9. Epub 2009 May 14.




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services